Medtronic PLC
$ 85.00
-1.38%
20 Apr - close price
- Market Cap 110,658,044,000 USD
- Current Price $ 85.00
- High / Low $ 87.05 / 84.99
- Stock P/E 24.08
- Book Value 38.17
- EPS 3.58
- Next Earning Report 2026-06-03
- Dividend Per Share $2.83
- Dividend Yield 3.3 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.09 %
- 52 Week High 104.70
- 52 Week Low 77.47
About
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Analyst Target Price
$109.08
Quarterly Earnings
| Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-17 | 2025-11-18 | 2025-08-19 | 2025-05-21 | 2025-02-18 | 2024-11-19 | 2024-08-20 | 2024-05-23 | 2024-02-20 | 2023-11-21 | 2023-08-22 | 2023-05-25 |
| Reported EPS | 1.36 | 1.36 | 1.26 | 1.62 | 1.39 | 1.26 | 1.23 | 1.46 | 1.3 | 1.25 | 1.2 | 1.57 |
| Estimated EPS | 1.33 | 1.31 | 1.23 | 1.58 | 1.36 | 1.25 | 1.2 | 1.45 | 1.26 | 1.18 | 1.11 | 1.56 |
| Surprise | 0.03 | 0.05 | 0.03 | 0.04 | 0.03 | 0.01 | 0.03 | 0.01 | 0.04 | 0.07 | 0.09 | 0.01 |
| Surprise Percentage | 2.2556% | 3.8168% | 2.439% | 2.5316% | 2.2059% | 0.8% | 2.5% | 0.6897% | 3.1746% | 5.9322% | 8.1081% | 0.641% |
Next Quarterly Earnings
| Apr 2026 | |
|---|---|
| Reported Date | 2026-06-03 |
| Fiscal Date Ending | 2026-04-30 |
| Estimated EPS | 1.59 |
| Currency | USD |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-17 | 2026-01-16 | 2025-10-17 | 2025-07-11 | 2025-04-11 | 2025-01-10 | 2024-10-11 | 2024-07-12 | 2024-04-12 | 2024-01-12 |
| Amount | $0.71 | $0.71 | $0.71 | $0.71 | $0.7 | $0.7 | $0.7 | $0.7 | $0.69 | $0.69 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MDT
2026-04-20 20:39:03
InspireMD (NSPR) announced its 2026 Annual Meeting of Stockholders for June 3, 2026, where shareholders will vote on re-electing three Class 3 directors, increasing authorized common shares from 150 million to 250 million, and ratifying Kesselman & Kesselman as the independent auditor. The company's board of directors recommends voting "FOR" all proposals. Holders of record as of April 10, 2026, will be eligible to vote.
2026-04-20 19:40:43
Intuitive Surgical's dominance in robotic-assisted surgery with its da Vinci platform is being tested by rising competition, yet its "razor-and-blades" business model continues to provide strong, recurring revenue. The article examines the company's core business, market position, competitive advantages, and the factors investors should consider, including risks like increased competition and regulatory hurdles. Ultimately, it suggests that the company's established installed base and ongoing innovation could sustain its market leadership.
2026-04-20 19:00:05
Google's 2026 Discover Core Update is altering how retail investors access information on Medtronic plc stock (IE00BTN1Y115), prioritizing personalized, mobile-first financial content. This update, completed by February 27, 2026, decouples Discover from traditional search, instead using Web and App Activity to proactively deliver tailored insights on Medtronic's performance, innovations, and market positioning directly to users' feeds. For investors, this means faster access to critical information on Medtronic's various segments and strategic moves, enhancing decision-making in the dynamic medtech sector.
2026-04-20 16:07:54
Medtronic has completed its acquisition of CathWorks for $585 million, marking its second tuck-in acquisition this year. This move aligns with Medtronic's strategy to bolster its core businesses through targeted M&A, particularly in cardiovascular and neuroscience. CathWorks' FFRangio system, which uses AI to assess coronary trees, is expected to be immaterial to Medtronic's fiscal 2027 earnings per share and then become neutral to accretive.
2026-04-20 13:06:57
Medtronic plc (NYSE: MDT) has finalized its acquisition of CathWorks, a medical device company focused on improving coronary artery disease (CAD) diagnosis and treatment, for $585 million plus potential earn-outs. This acquisition builds on a 2022 strategic partnership and integrates CathWorks' FFRangio System, which uses AI and advanced computational science for comprehensive physiological assessments without invasive wires. The deal aims to enhance Medtronic's interventional cardiology portfolio, expand global access to the technology, and reinforce Medtronic's leadership in digital transformation within cardiovascular care.
2026-04-20 12:55:57
Medtronic (NYSE:MDT) has completed its $585 million acquisition of CathWorks, a company specializing in advanced diagnostic technology for coronary artery disease. This acquisition aims to strengthen Medtronic's leadership in cardiovascular disease care by integrating CathWorks' FFRangio System, which uses angiography to assess coronary blockages.
